Overview

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

Status:
Recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
The proposed study is a multi-center, prospective randomized controlled trial comparing current standard of care treatment to the SEXTANT treatment protocol in patients with Type III open fractures of the tibia and IIIB fractures of the ankle and hindfoot.
Phase:
Phase 3
Details
Lead Sponsor:
Major Extremity Trauma Research Consortium
Treatments:
Tobramycin
Vancomycin